CN113278572A - Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof - Google Patents
Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof Download PDFInfo
- Publication number
- CN113278572A CN113278572A CN202110585915.3A CN202110585915A CN113278572A CN 113278572 A CN113278572 A CN 113278572A CN 202110585915 A CN202110585915 A CN 202110585915A CN 113278572 A CN113278572 A CN 113278572A
- Authority
- CN
- China
- Prior art keywords
- sequence
- seq
- gene
- hts
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101150102075 hts gene Proteins 0.000 title claims abstract description 34
- 241000186216 Corynebacterium Species 0.000 title claims abstract description 28
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 51
- 239000004472 Lysine Substances 0.000 claims abstract description 26
- 235000019766 L-Lysine Nutrition 0.000 claims abstract description 23
- 108091081024 Start codon Proteins 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 8
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 60
- 239000002773 nucleotide Substances 0.000 claims description 44
- 125000003729 nucleotide group Chemical group 0.000 claims description 40
- 238000011144 upstream manufacturing Methods 0.000 claims description 22
- 229930027917 kanamycin Natural products 0.000 claims description 20
- 229960000318 kanamycin Drugs 0.000 claims description 20
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 20
- 229930182823 kanamycin A Natural products 0.000 claims description 20
- 238000012408 PCR amplification Methods 0.000 claims description 19
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- 239000001963 growth medium Substances 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 239000013598 vector Substances 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 150000001413 amino acids Chemical group 0.000 claims description 12
- 239000001888 Peptone Substances 0.000 claims description 11
- 108010080698 Peptones Proteins 0.000 claims description 11
- 235000019319 peptone Nutrition 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- 238000000137 annealing Methods 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 241000186254 coryneform bacterium Species 0.000 claims description 6
- 238000004925 denaturation Methods 0.000 claims description 6
- 230000036425 denaturation Effects 0.000 claims description 6
- 238000012257 pre-denaturation Methods 0.000 claims description 6
- 238000011218 seed culture Methods 0.000 claims description 6
- 238000012795 verification Methods 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 4
- 238000010276 construction Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 230000007017 scission Effects 0.000 claims description 4
- 239000007836 KH2PO4 Substances 0.000 claims description 3
- 239000004395 L-leucine Substances 0.000 claims description 3
- 235000019454 L-leucine Nutrition 0.000 claims description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 239000012154 double-distilled water Substances 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 229960003136 leucine Drugs 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 241000186031 Corynebacteriaceae Species 0.000 claims 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract description 5
- 238000002715 modification method Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 13
- 230000009466 transformation Effects 0.000 description 7
- 102100025269 DENN domain-containing protein 2B Human genes 0.000 description 6
- 101000722264 Homo sapiens DENN domain-containing protein 2B Proteins 0.000 description 6
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 6
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108010061238 threonyl-glycine Proteins 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 2
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 2
- FAJIYNONGXEXAI-CQDKDKBSSA-N Ala-His-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 FAJIYNONGXEXAI-CQDKDKBSSA-N 0.000 description 2
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 2
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 2
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 2
- DRARURMRLANNLS-GUBZILKMSA-N Ala-Met-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O DRARURMRLANNLS-GUBZILKMSA-N 0.000 description 2
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- XLWSGICNBZGYTA-CIUDSAMLSA-N Arg-Glu-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XLWSGICNBZGYTA-CIUDSAMLSA-N 0.000 description 2
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 2
- JXMREEPBRANWBY-VEVYYDQMSA-N Asn-Thr-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JXMREEPBRANWBY-VEVYYDQMSA-N 0.000 description 2
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 2
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 2
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 2
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 2
- XHUCVVHRLNPZSZ-CIUDSAMLSA-N Glu-Gln-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XHUCVVHRLNPZSZ-CIUDSAMLSA-N 0.000 description 2
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 2
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 2
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 2
- RMWAOBGCZZSJHE-UMNHJUIQSA-N Glu-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N RMWAOBGCZZSJHE-UMNHJUIQSA-N 0.000 description 2
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 2
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 2
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 2
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 2
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 2
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 2
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 2
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 2
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- BIAKMWKJMQLZOJ-ZKWXMUAHSA-N His-Ala-Ala Chemical compound C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O BIAKMWKJMQLZOJ-ZKWXMUAHSA-N 0.000 description 2
- BSVLMPMIXPQNKC-KBPBESRZSA-N His-Phe-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O BSVLMPMIXPQNKC-KBPBESRZSA-N 0.000 description 2
- PPSQSIDMOVPKPI-BJDJZHNGSA-N Ile-Cys-Leu Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O PPSQSIDMOVPKPI-BJDJZHNGSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 2
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 2
- QUAAUWNLWMLERT-IHRRRGAJSA-N Leu-Arg-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O QUAAUWNLWMLERT-IHRRRGAJSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 2
- NTXYXFDMIHXTHE-WDSOQIARSA-N Leu-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 NTXYXFDMIHXTHE-WDSOQIARSA-N 0.000 description 2
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- HAQLBBVZAGMESV-IHRRRGAJSA-N Met-Lys-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O HAQLBBVZAGMESV-IHRRRGAJSA-N 0.000 description 2
- DBMLDOWSVHMQQN-XGEHTFHBSA-N Met-Ser-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DBMLDOWSVHMQQN-XGEHTFHBSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 2
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 2
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 2
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 2
- KWMUAKQOVYCQJQ-ZPFDUUQYSA-N Pro-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1 KWMUAKQOVYCQJQ-ZPFDUUQYSA-N 0.000 description 2
- CFVRJNZJQHDQPP-CYDGBPFRSA-N Pro-Ile-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 CFVRJNZJQHDQPP-CYDGBPFRSA-N 0.000 description 2
- RUDOLGWDSKQQFF-DCAQKATOSA-N Pro-Leu-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O RUDOLGWDSKQQFF-DCAQKATOSA-N 0.000 description 2
- KIDXAAQVMNLJFQ-KZVJFYERSA-N Pro-Thr-Ala Chemical compound C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(O)=O KIDXAAQVMNLJFQ-KZVJFYERSA-N 0.000 description 2
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 2
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 2
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 2
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 2
- PTWIYDNFWPXQSD-GARJFASQSA-N Ser-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N)C(=O)O PTWIYDNFWPXQSD-GARJFASQSA-N 0.000 description 2
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 2
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 2
- ONNSECRQFSTMCC-XKBZYTNZSA-N Thr-Glu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ONNSECRQFSTMCC-XKBZYTNZSA-N 0.000 description 2
- OLFOOYQTTQSSRK-UNQGMJICSA-N Thr-Pro-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLFOOYQTTQSSRK-UNQGMJICSA-N 0.000 description 2
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 2
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- ZJPSMXCFEKMZFE-IHPCNDPISA-N Trp-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O ZJPSMXCFEKMZFE-IHPCNDPISA-N 0.000 description 2
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 2
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 2
- VDPRBUOZLIFUIM-GUBZILKMSA-N Val-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N VDPRBUOZLIFUIM-GUBZILKMSA-N 0.000 description 2
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 2
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 2
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 108010054812 diprotin A Proteins 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 2
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZKGFMZJIENXHDL-UHFFFAOYSA-N 1,2-dihydropyridine-2,3-dicarboxylic acid Chemical compound OC(=O)C1NC=CC=C1C(O)=O ZKGFMZJIENXHDL-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 101150047086 arm gene Proteins 0.000 description 1
- JGGLZQUGOKVDGS-VYTIMWRQSA-N aspartate semialdehyde Chemical compound O[C@@H]1[C@@H](NC(=O)C)CO[C@H](CO)[C@H]1O[C@@H]1[C@@H](NC(C)=O)[C@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O)[C@@H](O)[C@H](CO[C@@H]3[C@H]([C@H](O[C@@H]4[C@H]([C@H](O)[C@@H](O)[C@H](CO)O4)O)[C@@H](O)[C@H](CO)O3)O)O2)O)[C@H](CO)O1 JGGLZQUGOKVDGS-VYTIMWRQSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y403/00—Carbon-nitrogen lyases (4.3)
- C12Y403/03—Amine-lyases (4.3.3)
- C12Y403/03007—4-Hydroxy-tetrahydrodipicolinate synthase (4.3.3.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a recombinant corynebacterium for modifying a 5' terminal sequence of an HTS gene and application thereof. The recombinant corynebacterium of the invention replaces nucleotide sequences from-19 to-12 before the initiation codon ATG in the 5 'end sequence of HTS gene in corynebacterium host bacteria, reduces the stability of the secondary structure of the 5' end sequence of HTS gene, and makes it easier to be transcribed or expressed. Compared with the original strain, the recombinant corynebacterium has certain improvement on the synthesis efficiency of L-lysine, further improves the yield of the L-lysine, reduces the production cost, has no conflict with the existing high-yield L-lysine modification method, but still needs to be further verified whether the recombinant corynebacterium has the mutual promotion effect with the existing modification method.
Description
Technical Field
The invention relates to a recombinant corynebacterium for modifying a 5' terminal sequence of an HTS gene and application thereof, belonging to the technical field of biological engineering.
Background
L-lysine is a basic unit constituting protein, is a raw material for synthesizing human body hormone, enzyme and antibody, participates in human body metabolism and various physiological activities, is essential amino acid for human body, and is basically available in various amino acid transfusion formulas. L-lysine was first isolated from a protein hydrolysate, and then a chemical synthesis method and an enzymatic method were invented, and was first produced by a microbial fermentation method in Japan in 1960. The L-lysine is prepared from various starch hydrolyzed sugar or molasses by fermenting with variant strains of Brevibacterium and Corynebacterium, separating, concentrating, evaporating, crystallizing, drying to obtain feed-grade lysine, and refining to obtain food-grade and pharmaceutical-grade lysine. The technology for producing glutamic acid by fermentation is comprehensively popularized in China in 1965, and scientific research and production of fermented lysine are driven since then. At present, the domestic lysine acid production rate and the conversion rate exceed 20g/dL and 60 percent.
Microorganisms for producing L-lysine include various species such as Corynebacterium, Bacillus, Escherichia, etc., but wild-type strains have poor L-lysine producing ability, many metabolic byproducts, and it is difficult to achieve the production of L-lysine with high purity and high yield. Therefore, it is generally desired to obtain a strain having a high L-lysine yield. At present, methods for obtaining strains with high L-lysine yield mainly comprise mutation screening breeding or genetic engineering breeding. The mutation screening breeding refers to inducing a strain to generate nonspecific gene site mutation by ultraviolet irradiation or other external condition stimulation, and then screening to obtain a high-yield strain. Genetic engineering breeding is to optimize the breeding strains by means of well-defined genetic engineering, for example, by introducing a beneficial enzyme gene with high enzymatic activity by increased copy or site-directed mutagenesis, or by knocking out an unfavorable gene to eliminate enzymatic activity/expression. Currently, Corynebacterium glutamicum CICC23604 has been widely used in industrial fermentation for producing various amino acids, and the product is approved as "general regulated as safe" (GRAS) by FDA. Therefore, the construction of the recombinant corynebacterium glutamicum by using a metabolic engineering means is an effective way for producing food safety-grade L-lysine.
The 5 'end sequence of a gene generally refers to a DNA sequence located upstream of the 5' end of a structural gene and generally comprising a transcription site recognized, bound and initiated by RNA polymerase, which contains conserved sequences required for RNA polymerase specific binding and transcription initiation, and which is not transcribed per se. Its properties were originally identified by mutations that increase or decrease the transcription rate of the gene. The promoter is generally located in the 5' end sequence of the gene, has a length which is different according to the organism, generally does not exceed 200bp, is a typical cis-acting element, and is combined with a transcription factor (trans-acting factor) to regulate the level, the position and the mode of gene expression (Chinese patent document CN 109385424A). Gene 5' end sequence substitutions may be used to modulate gene expression in a particular manner, such as their conditional expression or overexpression. PCR-based gene targeting, and chromosomal integration of regulatory sequences upstream of the Open Reading Frame (ORF) by homologous recombination, can stably alter the genome (chinese patent document CN 111655860A).
Although there are many reports on the improvement of L-lysine productivity, there is still a need to develop a novel method for improving L-lysine productivity.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a recombinant corynebacterium for modifying a 5' terminal sequence of an HTS gene and application thereof. The recombinant corynebacterium of the invention is obtained by modifying corynebacterium host bacteria through genetic engineering, and the specific strategy is to replace partial nucleotide sequence in 5 'end sequence of 4-hydroxy-tetrahydrodipicolinate synthase (HTS) gene by using a gene 5' end sequence replacement method to obtain the recombinant corynebacterium with high L-lysine yield.
Description of terms:
4-hydroxy-tetrahydrodipicolinate synthase (HTS): the enzyme catalyzing aspartate semialdehyde to form dihydropyridine dicarboxylic acid, which plays an important role in the synthesis of L-lysine, is widely present in various bacterial microorganisms.
The technical scheme of the invention is as follows:
a recombinant corynebacterium for modifying the 5 'end sequence of HTS gene features that the nucleotide sequence from-19 to-12 before the ATG start codon in the 5' end sequence of HTS gene is used in the corynebacterium host-19GAAGGTAA-12Is replaced by-19TGTGGTAT-12And the stability of the secondary structure of the 5' end sequence of the HTS gene is reduced, so that the HTS gene is easier to be transcribed or expressed.
Preferably according to the invention, the corynebacterium host bacterium is corynebacterium glutamicum; more preferably Corynebacterium glutamicum CICC23604 or Corynebacterium glutamicum CGMCC 1.15647.
Preferably according to the invention, the amino acid sequence of the HTS is SEQ ID NO.1 or SEQ ID NO. 8.
Preferably, according to the invention, the amino acid sequence of the HTS has an amino acid sequence with a sequence identity of at least 99.7% with the sequence of SEQ ID No.1 or SEQ ID No. 8.
Preferably, according to the invention, the nucleotide sequence of the HTS gene is SEQ ID NO.2 or SEQ ID NO. 9.
According to a preferred embodiment of the invention, the nucleotide sequence of the HTS gene has a nucleotide sequence with a sequence identity of 99.7% or more with SEQ ID NO.2 or SEQ ID NO. 9.
Preferably, according to the invention, the 5' end sequence of the HTS gene is SEQ ID NO.3 or SEQ ID NO. 10.
The construction method of the recombinant corynebacterium comprises the following steps:
(1) synthesis of upstream homology arm--19TGTGGTAT-12Nucleotide sequence of downstream homology arm, wherein upstream homology arm and downstream homology arm are nucleotide sequences from-19 to-12 before ATG (initiation codon) in 5' end sequence of HTS gene- 19GAAGGTAA-12A nucleotide sequence with the length of 500-600 bp is respectively arranged in front of and behind the nucleotide sequence;
(2) the upstream homology arm-19TGTGGTAT-12The nucleotide sequence of the downstream homology arm was ligated into the pK19mobsacB vector, constructing a replacement vector;
(3) transforming the replacement vector into a corynebacterium host strain competent cell, and screening a positive transformant with kanamycin resistance to obtain a recombinant strain with first homologous single exchange;
(4) and after natural passage of the recombinant bacteria subjected to the first homologous single exchange, screening bacterial colonies which can grow on a 10% sucrose culture medium but cannot grow on a kanamycin-resistant culture medium, and verifying to obtain the recombinant corynebacteria subjected to the two homologous single exchanges.
Preferably according to the invention, the upstream homology arm in step (2)-19TGTGGTAT-12The nucleotide sequence of the downstream homology arm is ligated between Hind III, EcoR I cleavage sites of the pK19mobsacB vector.
Preferably, in step (3), the kanamycin-resistant gene primers are used to screen for kanamycin-resistant positive transformants by using PCR amplification technology, and the sequences of the primers are as follows:
F1:5′-ATGATTGAACAAGATGGATTGC-3′,
R1:5′-TCAGAAGAACTCGTCAAGAAGGCG-3′。
preferably, the verification in step (4) is performed by using a PCR amplification technique, and the primer sequences amplified by PCR are as follows:
F2:5′-AAATGAGGGAATGTGGTAT-3′,
R2:5′-TTATAGAACTCCAGCTTTTTTCA-3′。
further preferably, the PCR amplification system is: 2 XHiFi-PCRmaster 10 μ L, 10 μmol/L forward primer 1 μ L, 10 μmol/L reverse primer 1 μ L, template 1 μ L, ddH2O 7μL;
The procedure of PCR amplification is as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃.
Preferably according to the invention, the medium used in step (4) is LBG medium: 5g/L of glucose, 10g/L of peptone, 5g/L of yeast extract and 10g/L of NaCl.
The use of the recombinant coryneform bacterium as described above for the production of L-lysine.
According to the invention, the application is that the recombinant corynebacterium is inoculated into the liquid LBG culture medium for seed culture, and then the recombinant corynebacterium is inoculated into the fermentation culture medium for fermentation culture according to the inoculum size of 2-5% by volume percentage;
the LBG medium: 5g/L of glucose, 10g/L of peptone, 5g/L of yeast extract and 10g/L of NaCl;
the fermentation medium comprises: 100g/L glucose, 20g/L peptone, 30mL/L corn steep liquor, 5g/L urea, (NH)4)2SO425g/L, L-leucine 0.34g/L, KH2PO4 2g/L,MgSO4·7H2O1.5g/L and biotin 0.001 g/L.
According to the preferable selection of the invention, the seed culture conditions are 200-220 rpm and 28-30 ℃ for 18-25 h; the fermentation culture conditions are 200-220 rpm and 28-30 ℃.
The technical principle of the invention is as follows:
the 5' end sequence of the gene comprises a promoter region sequence of the gene, and the secondary structure of the promoter region sequence can influence the promoter efficiency of the promoter and further influence the expression activity of the gene after the promoter. The invention relates to a method for preparing a HTS gene by a nucleotide sequence from-19 to-12 before an initiation codon ATG in a 5' end sequence of an HTS gene-19GAAGGTAA-12Is replaced by-19TGTGGTAT-12The stability of the secondary structure of the 5' end sequence of the HTS gene can be reduced, so that the HTS gene can be transcribed or expressed more easily.
Has the advantages that:
the invention provides a recombinant corynebacterium for modifying 5 'end sequence of HTS gene, which is a nucleotide sequence from-19 to-12 before ATG (initiation codon) in 5' end sequence of HTS gene-19GAAGGTAA-12Is replaced by-19TGTGGTAT-12Compared with the original strain, the recombinant corynebacterium has certain improvement on the synthesis efficiency of the L-lysine, further improves the yield of the L-lysine, reduces the production cost, has no conflict with the existing high-yield L-lysine modification method, but still needs to be further verified whether the recombinant corynebacterium has the mutual promotion effect with the existing modification method.
Detailed Description
The technical solution of the present invention is further described with reference to the following examples, but the scope of the present invention is not limited thereto. Reagents and medicines involved in the examples are all common commercial products unless otherwise specified; the experimental methods mentioned in the examples are all conventional technical means in the field unless otherwise specified.
The microbial source is as follows:
corynebacterium glutamicum CICC23604, purchased from China center for culture Collection of industrial microorganisms, with strain number CICC23604, wherein the amino acid sequence of 4-hydroxy-tetrahydrodipicolinate synthase (HTS) is SEQ ID NO.1, the nucleotide sequence of HTS gene is SEQ ID NO.2, and the 5' end sequence of HTS gene is SEQ ID NO. 3.
Corynebacterium glutamicum CGMCC1.15647 purchased from China general microbiological culture Collection center with the strain number of CGMCC1.15647, wherein the amino acid sequence of 4-hydroxy-tetrahydrodipicolinate synthase (HTS) is SEQ ID NO.8, the nucleotide sequence of HTS gene is SEQ ID NO.9, and the 5' end sequence of HTS gene is SEQ ID NO. 10.
The consistency of the amino acid sequences of SEQ ID NO.1 and SEQ ID NO.8 is 99.7%, the consistency of the nucleotide sequences of SEQ ID NO.2 and SEQ ID NO.9 is 99.7%, and the consistency of the nucleotide sequences of SEQ ID NO.3 and SEQ ID NO.10 is 100%.
The corn steep liquor referred to in the examples is corn steep liquor specially used for fermentation, and is available from biotech ltd.
Example 1: homologous arm gene synthesis containing replacement nucleotide sequence and construction of replacement vector
1.1 Corynebacterium glutamicum CICC23604
Synthesis of upstream homology arm for C.glutamicum CICC23604-19TGTGGTAT-12Nucleotide sequence of downstream homology arm, upstream homology arm and downstream homology arm being nucleotide sequences from-19 to-12 before ATG initiation codon in 5' end sequence of HTS gene-19GAAGGTAA-12The nucleotide sequence of 500bp length is respectively arranged in front of and behind the upstream homology arm, wherein the nucleotide sequence of the upstream homology arm is SEQ ID NO.4, the nucleotide sequence of the downstream homology arm is SEQ ID NO.5, and the original upstream homology arm- 19GAAGGTAA-12The nucleotide sequence of the downstream homology arm is SEQ ID NO.6, the upstream homology arm being designed for synthesis- 19TGTGGTAT-12The nucleotide sequence of the downstream homology arm is SEQ ID No. 7. The nucleotide sequence of SEQ ID NO.7 was synthesized by Shanghai Bioengineering Co., Ltd and ligated between Hind III and EcoRI cleavage sites of pK19mobsacB vector (GenBank: LC 257601.1). The ligation products were transformed into E.coli DH 5. alpha. competent cells, 200. mu.L of the transformation solution was spread on solid LB plates containing kanamycin antibiotic (50. mu.g/mL final concentration) using a sterilized spreader, cultured overnight in an incubator at 37 ℃ and screened for positive transformants for extraction and preservation of the replacement vector pK19mobsacB-HTS 1.
1.2 Corynebacterium glutamicum CGMCC1.15647
Synthesis of upstream homology arm for Corynebacterium glutamicum CGMCC1.15647-19TGTGGTAT-12Nucleotide sequence of downstream homology arm, upstream homology arm and downstream homology arm being nucleotide sequences from-19 to-12 before ATG initiation codon in 5' end sequence of HTS gene-19GAAGGTAA-12The nucleotide sequence of 500bp length is respectively arranged in front of and behind the upstream homology arm, wherein the nucleotide sequence of the upstream homology arm is SEQ ID NO.11, the nucleotide sequence of the downstream homology arm is SEQ ID NO.12, and the original upstream homology arm-19GAAGGTAA-12The nucleotide sequence of the downstream homology arm is SEQ ID NO.13, the upstream homology arm being designed for synthesis- 19TGTGGTAT-12The nucleotide sequence of the downstream homology arm is SEQ ID No. 14. The nucleotide sequence of SEQ ID NO.14 was synthesized by Shanghai Bioengineering Co., Ltd and ligated between Hind III and EcoR I cleavage sites of pK19mobsacB vector (GenBank: LC 257601.1). The ligation products were transformed into E.coli DH 5. alpha. competent cells, 200. mu.L of the transformation solution was spread on solid LB plates containing kanamycin antibiotic (50. mu.g/mL final concentration) using a sterilized spreader, cultured overnight in an incubator at 37 ℃ and screened for positive transformants for extraction and preservation of the replacement vector pK19mobsacB-HTS 2.
Example 2: preparation of Corynebacterium glutamicum CICC23604/CGMCC1.15647 competent cell
(1) Picking single corynebacterium glutamicum colony, inoculating the single corynebacterium glutamicum colony in 10mL of seed culture medium, culturing at 37 ℃ at 220r/min overnight;
seed medium (1000mL), composition as follows: 10g of peptone, 5g of yeast powder, 10g of sodium chloride and 91g of sorbitol;
(2) transferring 1mL of the above bacterial solution into 100mL of seed culture medium, culturing at 37 deg.C and 220r/min to OD600=0.9;
(3) Transferring the bacterial liquid to a 100mL centrifuge tube, and carrying out ice bath for 15-20min to stop the growth of thalli;
(4) centrifuging at 4 deg.C and 5000r/min for 5min after ice bath, and collecting thallus;
(5) the centrifuged cells were washed 3 times with pre-cooled electrotransfer buffer (ETM);
electrotransfer buffer (1000mL), composition per liter as follows: 91g of sorbitol, 91g of mannitol and 100mL of glycerol;
(6) after washing, resuspending the thallus with 1000 μ L of electrotransfer buffer solution to obtain competent cells;
(7) the prepared competent cells are subpackaged in 100 mu L/tube and stored at-80 ℃ for later use.
Example 3: replacement vector electrotransformation of corynebacterium glutamicum competent cells
Firstly, a nucleic acid ultramicro spectrophotometer is utilized to measure the concentration of a replacement vector pK19mobsacB-HTS1 or pK19mobsacB-HTS2 fragment, 1800V electric shock is carried out for 5ms after the concentration reaches 300 mu g/mL, the electric transformation is carried out, the electric transformation is respectively carried out on the electric transformation to corynebacterium glutamicum CICC23604 competent cells and corynebacterium glutamicum CGMCC1.15647 competent cells, the obtained cells are recovered and cultured for 1h at 30 ℃ by using a liquid recovery culture medium, 100 mu L of the electric transformation is taken to be coated on an LB solid culture medium containing 25 mu g/mL kanamycin, the electric transformation is carried out for 2 days at 37 ℃, and corynebacterium glutamicum CICC23604 transformants with kanamycin resistance and corynebacterium glutamicum CGMCC1.15647 transformants with kanamycin resistance are respectively screened.
Wherein the liquid recovery culture medium comprises the following components per 1000 mL: 10g of peptone, 5g of yeast powder, 10g of sodium chloride, 91g of sorbitol and 69.4g of mannitol.
Example 4: culture and identification of positive recombinant bacteria
(1) Kanamycin-resistant flat plate primary screen
Selecting single colonies on the kanamycin-resistant plate in example 3, respectively inoculating the single colonies in a liquid LBG culture medium containing 25 mug/mL kanamycin, extracting a genome as a template DNA, and performing PCR amplification by using a kanamycin-resistant gene primer for verification, wherein a target band at 795bp is a positive transformant;
wherein the LBG medium: 5g/L of glucose, 10g/L of peptone, 5g/L of yeast extract and 10g/L of NaCl;
the kanamycin resistance gene primer sequences are as follows:
F1:5′-ATGATTGAACAAGATGGATTGC-3′,
R1:5′-TCAGAAGAACTCGTCAAGAAGGCG-3′;
the PCR amplification system is as follows:
TABLE 1 PCR amplification System
The PCR amplification procedure was as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃.
Strains with specific bands at 795bp were selected for further validation as strains with homologous single crossover.
(2) Sucrose flat plate double screen
Respectively inoculating the strains which are verified to be correct and have homologous single exchange into a liquid LBG culture medium without antibiotics, carrying out natural passage for 3 times, carrying out 24-hour culture in each generation, finally coating 200 mu L of bacterial liquid on an LBG solid culture medium (without antibiotics) containing 10% of sucrose, selecting bacterial colonies, carrying out dibbling on the LBG solid culture medium with kanamycin resistance (25 mu g/mL) for culture, screening bacterial colonies which can grow on the LBG culture medium with 10% of sucrose but cannot grow on the LBG culture medium with kanamycin resistance, extracting genomes, and verifying by adopting PCR amplification;
wherein the primer sequences for PCR amplification are as follows:
F2:5′-AAATGAGGGAATGTGGTAT-3′,
R2:5′-TTATAGAACTCCAGCTTTTTTCA-3′;
the 3' terminal sequence of the F2 primer contains a site after substitution-19TGTGGTAT-12;
The PCR amplification system is as follows:
TABLE 2 PCR amplification System
The PCR amplification procedure was as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃.
Specific bands at 936bp are selected and respectively connected to pMD18-T vectors, vector primers are adopted for sequencing, and recombinant corynebacterium glutamicum HTS1 and HTS2 which complete two times of homologous single exchange are obtained after verification.
Example 5: stability verification of recombinant Corynebacterium glutamicum
The screened and verified recombinant corynebacterium glutamicum HTS1 and HTS2 are subjected to subculture respectively, a single colony on a plate is selected and inoculated into a liquid LBG culture medium without antibiotics for 12 hours, then continuous subculture is carried out for 30 generations according to the inoculum size of 1% by volume percentage, the last generation of bacterial liquid is taken for genome extraction, and colony PCR verification is carried out by taking F2 and R2 as primers. The results show that the use of primers F2 and R2 can amplify a specific gene band of about 936bp, which is consistent with the theoretical value, demonstrating that the substitution is-19TGTGGTAT-12Has successfully integrated and stably exists on the genomes of recombinant corynebacterium glutamicum HTS1 and HTS 2;
wherein, the PCR amplification system comprises the following components:
TABLE 3 PCR amplification System
The PCR amplification procedure was as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃.
Example 6: l-lysine fermentation test
The recombinant corynebacterium glutamicum HTS1 and HTS2 prepared above were inoculated into 100mL of BG culture medium (glucose 5g/L, peptone 10g/L, yeast extract 5g/L, NaCl10g/L), respectively, and seed-cultured at 30 ℃ and 220rpm for 20 hours, after which it was inoculated into 100mL of fermentation medium (glucose 100g/L,peptone 20g/L, corn steep liquor 30mL/L, urea 5g/L, (NH)4)2SO425g/L, L-leucine 0.34g/L, KH2PO42g/L,MgSO4·7H2O1.5g/L, biotin 0.001g/L) was cultured for 48 hours, samples were taken every 12 hours, and the content of L-lysine in the fermentation broth was measured by biosensing analyzer SBA-40C (biological research, manufactured by institute of sciences, Shandong province), with the results shown in tables 4 and 5.
TABLE 4 average production of L-lysine from various time points of recombinant Corynebacterium glutamicum HTS1 and of the original strain
TABLE 5 average production of L-lysine from various time points of recombinant Corynebacterium glutamicum HTS2 and the original strain
The results show that the L-lysine content in the recombinant Corynebacterium glutamicum HTS1 fermentation broth reaches 43.9g/L and is increased by 6.8% compared with the original strain after 48h of fermentation, and the L-lysine content in the recombinant Corynebacterium glutamicum HTS2 fermentation broth reaches 1.02g/L which is 2.32 times of that of the original strain, which indicates that the nucleotide sequence from the front-19 to the-12 of the ATG of the initiation codon in the 5' end sequence of the Corynebacterium glutamicum HTS gene-19GAAGGTAA-12Is replaced by-19TGTGGTAT-12The fermentation level of the L-lysine can be improved, and the method is a novel method for improving the yield of the L-lysine.
The stability analysis of the sequences before and after the replacement of the nucleotide sequence from the position-19 to the position-12 before the initiation codon ATG in the 5 ' end sequence of the HTS gene in the Corynebacterium glutamicum CICC23604 and CGMCC1.15647 (SEQ ID NO.3 and SEQ ID NO.10) was performed by using RNAfold web server (http:// rna.tbi.univie.ac.at/cgi-bin/RNAwebsuite/RNAfold.cgi), and the results showed that the sequences before and after the replacement of the nucleotide sequence from the position-19 to the position-12 before the initiation codon ATG in the 5 ' end sequence of the HTS gene in the Corynebacterium glutamicum CICC23604 and CGMCC1.15647 were stable, and the results showed that the sequences after the replacement of the nucleotide sequence from the position-19 to the position-12 before the initiation codon ATG in the 5 ' end sequence of the HTS gene in the Corynebacterium glutamicum CICC23604 and CGMCC1.15647Nucleotide sequence-19GAAGGTAA-12Is replaced by-19TGTGGTAT-12Then, the minimum free energy (minimum free energy) of the 5' -terminal sequence was increased from-44.6 kcal/mol to-44.2 kcal/mol. This indicates that sequence replacement can reduce the stability of the 5' terminal sequence, which in turn makes the HTS gene easier to be transcribed and translated, and ultimately increases the acid production level of amino acid fermentation.
SEQUENCE LISTING
<110> university of Qilu Industrial science
ZHUCHENG DONGXIAO BIOTECHNOLOGY Co.,Ltd.
<120> recombinant corynebacterium for modifying 5' terminal sequence of HTS gene and application thereof
<160> 14
<170> PatentIn version 3.5
<210> 1
<211> 301
<212> PRT
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 1
Met Ser Thr Gly Leu Thr Ala Lys Thr Gly Val Glu His Phe Gly Thr
1 5 10 15
Val Gly Val Ala Met Val Thr Pro Phe Thr Glu Ser Gly Asp Ile Asp
20 25 30
Ile Ala Ala Gly Arg Glu Val Ala Ala Tyr Leu Val Asp Lys Gly Leu
35 40 45
Asp Ser Leu Val Leu Ala Gly Thr Thr Gly Glu Ser Pro Thr Thr Thr
50 55 60
Ala Ala Glu Lys Leu Glu Leu Leu Lys Ala Val Arg Glu Glu Val Gly
65 70 75 80
Asp Arg Ala Lys Leu Ile Ala Gly Val Gly Thr Asn Asn Thr Arg Thr
85 90 95
Ser Val Glu Leu Ala Glu Ala Ala Ala Ser Ala Gly Ala Asp Gly Leu
100 105 110
Leu Val Val Thr Pro Tyr Tyr Ser Lys Pro Ser Gln Glu Gly Leu Leu
115 120 125
Ala His Phe Gly Ala Ile Ala Ala Ala Thr Glu Val Pro Ile Cys Leu
130 135 140
Tyr Asp Ile Pro Gly Arg Ser Gly Ile Pro Ile Glu Ser Asp Thr Met
145 150 155 160
Arg Arg Leu Ser Glu Leu Pro Thr Ile Leu Ala Val Lys Asp Ala Lys
165 170 175
Gly Asp Leu Val Ala Ala Thr Ser Leu Ile Lys Glu Thr Gly Leu Ala
180 185 190
Trp Tyr Ser Gly Asp Asp Pro Leu Asn Leu Val Trp Leu Ala Leu Gly
195 200 205
Gly Ser Gly Phe Ile Ser Val Ile Gly His Ala Ala Pro Thr Ala Leu
210 215 220
Arg Glu Leu Tyr Thr Ser Phe Glu Glu Gly Asp Leu Val Arg Ala Arg
225 230 235 240
Glu Ile Asn Ala Lys Leu Ser Pro Leu Val Ala Ala Gln Gly Arg Leu
245 250 255
Gly Gly Val Ser Leu Ala Lys Ala Ala Leu Arg Leu Gln Gly Ile Asn
260 265 270
Val Gly Asp Pro Arg Leu Pro Ile Met Ala Pro Asn Glu Gln Glu Leu
275 280 285
Glu Ala Leu Arg Glu Asp Met Lys Lys Ala Gly Val Leu
290 295 300
<210> 2
<211> 906
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 2
atgagcacag gtttaacagc taagaccgga gtagagcact tcggcaccgt tggagtagca 60
atggttactc cattcacgga atccggagac atcgatatcg ctgctggccg cgaagtcgcg 120
gcttatttgg ttgataaggg cttggattct ttggttctcg cgggcaccac tggtgaatcc 180
ccaacgacaa ccgccgctga aaaactagaa ctgctcaagg ccgttcgtga ggaagttggg 240
gatcgggcga agctcatcgc cggtgtcgga accaacaaca cgcggacatc tgtggaactt 300
gcggaagctg ctgcttctgc tggcgcagac ggccttttag ttgtaactcc ttattactcc 360
aagccgagcc aagagggatt gctggcgcac ttcggtgcaa ttgctgcagc aacagaggtt 420
ccaatttgtc tctatgacat tcctggtcgg tcaggtattc caattgagtc tgataccatg 480
agacgcctga gtgaattacc tacgattttg gcggtcaagg acgccaaggg tgacctcgtt 540
gcagccacgt cattgatcaa agaaacggga cttgcctggt attcaggcga tgacccacta 600
aaccttgttt ggcttgcttt gggcggatca ggtttcattt ccgtaattgg acatgcagcc 660
cccacagcat tacgtgagtt gtacacaagc ttcgaggaag gcgacctcgt ccgtgcgcgg 720
gaaatcaacg ccaaactatc accgctggta gctgcccaag gtcgcttggg tggagtcagc 780
ttggcaaaag ctgctctgcg tctgcagggc atcaacgtag gagatcctcg acttccaatt 840
atggctccaa atgagcagga acttgaggct ctccgagaag acatgaaaaa agctggagtt 900
ctataa 906
<210> 3
<211> 150
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 3
tttggctgta aaagacagcc gtaaaaacct cttgctcatg tcaattgttc ttatcggaat 60
gtggcttggg cgattgttat gcaaaagttg ttaggttttt tgcggggttg tttaaccccc 120
aaatgaggga agaaggtaac cttgaactct 150
<210> 4
<211> 500
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 4
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcacttt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtggt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgtcgaaatc cgcgaagtag cggtaggatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atatagttaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa 500
<210> 5
<211> 500
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 5
ccttgaactc tatgagcaca ggtttaacag ctaagaccgg agtagagcac ttcggcaccg 60
ttggagtagc aatggttact ccattcacgg aatccggaga catcgatatc gctgctggcc 120
gcgaagtcgc ggcttatttg gttgataagg gcttggattc tttggttctc gcgggcacca 180
ctggtgaatc cccaacgaca accgccgctg aaaaactaga actgctcaag gccgttcgtg 240
aggaagttgg ggatcgggcg aagctcatcg ccggtgtcgg aaccaacaac acgcggacat 300
ctgtggaact tgcggaagct gctgcttctg ctggcgcaga cggcctttta gttgtaactc 360
cttattactc caagccgagc caagagggat tgctggcgca cttcggtgca attgctgcag 420
caacagaggt tccaatttgt ctctatgaca ttcctggtcg gtcaggtatt ccaattgagt 480
ctgataccat gagacgcctg 500
<210> 6
<211> 1008
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CICC23604
<400> 6
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcacttt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtggt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgtcgaaatc cgcgaagtag cggtaggatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atatagttaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa gaaggtaacc ttgaactcta tgagcacagg tttaacagct 540
aagaccggag tagagcactt cggcaccgtt ggagtagcaa tggttactcc attcacggaa 600
tccggagaca tcgatatcgc tgctggccgc gaagtcgcgg cttatttggt tgataagggc 660
ttggattctt tggttctcgc gggcaccact ggtgaatccc caacgacaac cgccgctgaa 720
aaactagaac tgctcaaggc cgttcgtgag gaagttgggg atcgggcgaa gctcatcgcc 780
ggtgtcggaa ccaacaacac gcggacatct gtggaacttg cggaagctgc tgcttctgct 840
ggcgcagacg gccttttagt tgtaactcct tattactcca agccgagcca agagggattg 900
ctggcgcact tcggtgcaat tgctgcagca acagaggttc caatttgtct ctatgacatt 960
cctggtcggt caggtattcc aattgagtct gataccatga gacgcctg 1008
<210> 7
<211> 1008
<212> DNA
<213> Artificial sequence
<220>
<221> misc_feature
<222> (501)..(508)
<223> replacement of the original nucleotide sequence GAAGGTAA by TGTGGTAT
<400> 7
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcacttt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtggt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgtcgaaatc cgcgaagtag cggtaggatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atatagttaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa tgtggtatcc ttgaactcta tgagcacagg tttaacagct 540
aagaccggag tagagcactt cggcaccgtt ggagtagcaa tggttactcc attcacggaa 600
tccggagaca tcgatatcgc tgctggccgc gaagtcgcgg cttatttggt tgataagggc 660
ttggattctt tggttctcgc gggcaccact ggtgaatccc caacgacaac cgccgctgaa 720
aaactagaac tgctcaaggc cgttcgtgag gaagttgggg atcgggcgaa gctcatcgcc 780
ggtgtcggaa ccaacaacac gcggacatct gtggaacttg cggaagctgc tgcttctgct 840
ggcgcagacg gccttttagt tgtaactcct tattactcca agccgagcca agagggattg 900
ctggcgcact tcggtgcaat tgctgcagca acagaggttc caatttgtct ctatgacatt 960
cctggtcggt caggtattcc aattgagtct gataccatga gacgcctg 1008
<210> 8
<211> 301
<212> PRT
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 8
Met Ser Thr Gly Leu Thr Ala Lys Thr Gly Val Glu His Phe Gly Thr
1 5 10 15
Val Gly Val Ala Met Val Thr Pro Phe Thr Glu Ser Gly Asp Ile Asp
20 25 30
Ile Ala Ala Gly Arg Glu Leu Ala Ala Tyr Leu Val Asp Lys Gly Leu
35 40 45
Asp Ser Leu Val Leu Ala Gly Thr Thr Gly Glu Ser Pro Thr Thr Thr
50 55 60
Ala Ala Glu Lys Leu Glu Leu Leu Lys Ala Val Arg Glu Glu Val Gly
65 70 75 80
Asp Arg Ala Lys Leu Ile Ala Gly Val Gly Thr Asn Asn Thr Arg Thr
85 90 95
Ser Val Glu Leu Ala Glu Ala Ala Ala Ser Ala Gly Ala Asp Gly Leu
100 105 110
Leu Val Val Thr Pro Tyr Tyr Ser Lys Pro Ser Gln Glu Gly Leu Leu
115 120 125
Ala His Phe Gly Ala Ile Ala Ala Ala Thr Glu Val Pro Ile Cys Leu
130 135 140
Tyr Asp Ile Pro Gly Arg Ser Gly Ile Pro Ile Glu Ser Asp Thr Met
145 150 155 160
Arg Arg Leu Ser Glu Leu Pro Thr Ile Leu Ala Val Lys Asp Ala Lys
165 170 175
Gly Asp Leu Val Ala Ala Thr Ser Leu Ile Lys Glu Thr Gly Leu Ala
180 185 190
Trp Tyr Ser Gly Asp Asp Pro Leu Asn Leu Val Trp Leu Ala Leu Gly
195 200 205
Gly Ser Gly Phe Ile Ser Val Ile Gly His Ala Ala Pro Thr Ala Leu
210 215 220
Arg Glu Leu Tyr Thr Ser Phe Glu Glu Gly Asp Leu Val Arg Ala Arg
225 230 235 240
Glu Ile Asn Ala Lys Leu Ser Pro Leu Val Ala Ala Gln Gly Arg Leu
245 250 255
Gly Gly Val Ser Leu Ala Lys Ala Ala Leu Arg Leu Gln Gly Ile Asn
260 265 270
Val Gly Asp Pro Arg Leu Pro Ile Met Ala Pro Asn Glu Gln Glu Leu
275 280 285
Glu Ala Leu Arg Glu Asp Met Lys Lys Ala Gly Val Leu
290 295 300
<210> 9
<211> 906
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 9
atgagcacag gtttaacagc taagaccgga gtagagcact tcggcaccgt tggagtagca 60
atggttactc cattcacgga atccggagac atcgatatcg ctgctggccg cgagctcgcg 120
gcttatttgg ttgataaggg cttggattct ttggttctcg cgggcaccac tggtgaatcc 180
ccaacgacaa ctgccgctga aaaactagaa ctgctcaagg ccgttcgtga ggaagttggg 240
gatcgggcga agctcatcgc cggtgtcgga accaacaaca cgcggacatc tgtggaactt 300
gcggaagctg ctgcttctgc tggcgcagac ggccttttag ttgtaactcc ttattactcc 360
aagccgagcc aagagggatt gctggcgcac ttcggtgcaa ttgctgcagc aacagaggtt 420
ccaatttgtc tctatgacat tcctggtcgg tcaggtattc caattgagtc tgataccatg 480
agacgcctga gtgaattacc tacgattttg gcggtcaagg acgccaaggg tgacctcgtt 540
gcagccacgt cattgatcaa agaaacggga cttgcctggt attcaggcga tgacccacta 600
aaccttgttt ggcttgcttt gggcggatca ggtttcattt ccgtaattgg acatgcagcc 660
cccacagcat tacgtgagtt gtacacaagc ttcgaggaag gcgacctcgt ccgtgcgcgg 720
gaaatcaacg ccaaactatc accgctggta gctgcccaag gtcgcttggg tggagtcagc 780
ttggcaaaag ctgctctgcg tctgcagggc atcaacgtag gagatcctcg acttccaatt 840
atggctccaa atgagcagga acttgaggct ctccgagaag acatgaaaaa agctggagtt 900
ctataa 906
<210> 10
<211> 150
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 10
tttggctgta aaagacagcc gtaaaaacct cttgctcatg tcaattgttc ttatcggaat 60
gtggcttggg cgattgttat gcaaaagttg ttaggttttt tgcggggttg tttaaccccc 120
aaatgaggga agaaggtaac cttgaactct 150
<210> 11
<211> 500
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 11
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcaattt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtagt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgttgaaatc cgcgaagtag cggtagaatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atataggtaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa 500
<210> 12
<211> 500
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 12
ccttgaactc tatgagcaca ggtttaacag ctaagaccgg agtagagcac ttcggcaccg 60
ttggagtagc aatggttact ccattcacgg aatccggaga catcgatatc gctgctggcc 120
gcgagctcgc ggcttatttg gttgataagg gcttggattc tttggttctc gcgggcacca 180
ctggtgaatc cccaacgaca actgccgctg aaaaactaga actgctcaag gccgttcgtg 240
aggaagttgg ggatcgggcg aagctcatcg ccggtgtcgg aaccaacaac acgcggacat 300
ctgtggaact tgcggaagct gctgcttctg ctggcgcaga cggcctttta gttgtaactc 360
cttattactc caagccgagc caagagggat tgctggcgca cttcggtgca attgctgcag 420
caacagaggt tccaatttgt ctctatgaca ttcctggtcg gtcaggtatt ccaattgagt 480
ctgataccat gagacgcctg 500
<210> 13
<211> 1008
<212> DNA
<213> Corynebacterium glutamicum (Corynebacterium glutamicum) CGMCC1.15647
<400> 13
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcaattt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtagt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgttgaaatc cgcgaagtag cggtagaatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atataggtaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa gaaggtaacc ttgaactcta tgagcacagg tttaacagct 540
aagaccggag tagagcactt cggcaccgtt ggagtagcaa tggttactcc attcacggaa 600
tccggagaca tcgatatcgc tgctggccgc gagctcgcgg cttatttggt tgataagggc 660
ttggattctt tggttctcgc gggcaccact ggtgaatccc caacgacaac tgccgctgaa 720
aaactagaac tgctcaaggc cgttcgtgag gaagttgggg atcgggcgaa gctcatcgcc 780
ggtgtcggaa ccaacaacac gcggacatct gtggaacttg cggaagctgc tgcttctgct 840
ggcgcagacg gccttttagt tgtaactcct tattactcca agccgagcca agagggattg 900
ctggcgcact tcggtgcaat tgctgcagca acagaggttc caatttgtct ctatgacatt 960
cctggtcggt caggtattcc aattgagtct gataccatga gacgcctg 1008
<210> 14
<211> 1008
<212> DNA
<213> Artificial sequence
<220>
<221> misc_feature
<222> (501)..(508)
<223> replacement of the original nucleotide sequence GAAGGTAA by TGTGGTAT
<400> 14
gctgcttaat gcgctggaag aaaaacttgg cgatgaaccg aatgcaattt taaggaaaaa 60
gcaggctcgt caagcagctc gcgctgtgct gcccaacgct acagagtcca gaatcgtagt 120
gtctggaaac ttccgcacct ggaggcattt cattggcatg cgagccagtg aacatgcaga 180
cgttgaaatc cgcgaagtag cggtagaatg tttaagaaag ctgcaggtag cagcgccaac 240
tgttttcggt gattttgaga ttgaaacttt ggcagacgga tcgcaaatgg caacaagccc 300
gtatgtcatg gacttttaac gcaaagctca cacccacgag ctaaaaattc atataggtaa 360
gacaacattt ttggctgtaa aagacagccg taaaaacctc ttgctcatgt caattgttct 420
tatcggaatg tggcttgggc gattgttatg caaaagttgt taggtttttt gcggggttgt 480
ttaaccccca aatgagggaa tgtggtatcc ttgaactcta tgagcacagg tttaacagct 540
aagaccggag tagagcactt cggcaccgtt ggagtagcaa tggttactcc attcacggaa 600
tccggagaca tcgatatcgc tgctggccgc gagctcgcgg cttatttggt tgataagggc 660
ttggattctt tggttctcgc gggcaccact ggtgaatccc caacgacaac tgccgctgaa 720
aaactagaac tgctcaaggc cgttcgtgag gaagttgggg atcgggcgaa gctcatcgcc 780
ggtgtcggaa ccaacaacac gcggacatct gtggaacttg cggaagctgc tgcttctgct 840
ggcgcagacg gccttttagt tgtaactcct tattactcca agccgagcca agagggattg 900
ctggcgcact tcggtgcaat tgctgcagca acagaggttc caatttgtct ctatgacatt 960
cctggtcggt caggtattcc aattgagtct gataccatga gacgcctg 1008
Claims (10)
1. A recombinant corynebacterium for modifying the 5 'end sequence of HTS gene features that the nucleotide sequence before-19-12 bits of ATG as start codon in the 5' end sequence of HTS gene is inserted in the host corynebacterium-19GAAGGTAA-12Is replaced by- 19TGTGGTAT-12And the stability of the secondary structure of the 5' end sequence of the HTS gene is reduced, so that the HTS gene is easier to be transcribed or expressed.
2. The recombinant coryneform bacterium according to claim 1, wherein said coryneform host bacterium is Corynebacterium glutamicum;
preferably, the corynebacterium glutamicum is corynebacterium glutamicum CICC23604 or corynebacterium glutamicum CGMCC 1.15647.
3. The recombinant coryneform bacterium according to claim 1, wherein the amino acid sequence of said HTS is SEQ ID No.1 or SEQ ID No. 8;
preferably, the amino acid sequence of the HTS has an amino acid sequence with a sequence identity of 99.7% or more with the sequence of SEQ ID No.1 or SEQ ID No. 8.
4. The recombinant coryneform bacterium according to claim 1, wherein the nucleotide sequence of said HTS gene is SEQ ID No.2 or SEQ ID No. 9;
preferably, the nucleotide sequence of the HTS gene is a nucleotide sequence with the sequence identity of SEQ ID NO.2 or SEQ ID NO.9 of more than or equal to 99.7%.
5. The recombinant coryneform bacterium according to claim 1, wherein the 5' -end sequence of said HTS gene is SEQ ID No.3 or SEQ ID No. 10.
6. The method of constructing recombinant coryneform bacteria according to claim 1, comprising the steps of:
(1) synthesis of upstream homology arm--19TGTGGTAT-12Nucleotide sequence of downstream homology arm, wherein upstream homology arm and downstream homology arm are nucleotide sequences from-19 to-12 before ATG (initiation codon) in 5' end sequence of HTS gene-19GAAGGTAA-12A nucleotide sequence with the length of 500-600 bp is respectively arranged in front of and behind the nucleotide sequence;
(2) the upstream homology arm-19TGTGGTAT-12The nucleotide sequence of the downstream homology arm was ligated into the pK19mobsacB vector, constructing a replacement vector;
(3) transforming the replacement vector into a corynebacterium host strain competent cell, and screening a positive transformant with kanamycin resistance to obtain a recombinant strain with first homologous single exchange;
(4) and after natural passage of the recombinant bacteria subjected to the first homologous single exchange, screening bacterial colonies which can grow on a 10% sucrose culture medium but cannot grow on a kanamycin-resistant culture medium, and verifying to obtain the recombinant corynebacteria subjected to the two homologous single exchanges.
7. The construction method according to claim 6, wherein one or more of the following conditions are satisfied:
i. upstream homology arm in step (2)-19TGTGGTAT-12The nucleotide sequence of the downstream homology arm is ligated between Hind III, EcoR I cleavage sites of the pK19mobsacB vector;
screening positive transformants with kanamycin resistance in step (3) by using PCR amplification technology with kanamycin resistance gene primers having the following sequences:
F1:5′-ATGATTGAACAAGATGGATTGC-3′,
R1:5′-TCAGAAGAACTCGTCAAGAAGGCG-3′;
the PCR amplification system comprises: 2 XHiFi-PCRmaster 10 μ L, 10 μmol/L forward primer 1 μ L, 10 μmol/L reverse primer 1 μ L, template 1 μ L, ddH2O 7μL;
The procedure of PCR amplification is as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃;
the verification in the step (4) is verified by adopting a PCR amplification technology, and the sequence of the primer amplified by the PCR is as follows:
F2:5′-AAATGAGGGAATGTGGTAT-3′,
R2:5′-TTATAGAACTCCAGCTTTTTTCA-3′;
the PCR amplification system comprises: 2 XHiFi-PCRmaster 10 μ L, 10 μmol/L forward primer 1 μ L, 10 μmol/L reverse primer 1 μ L, template 1 μ L, ddH2O 7μL;
The procedure of PCR amplification is as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30sec, annealing at 56 ℃ for 30sec, extension at 72 ℃ for 1min, 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃;
the medium used in step (4) is LBG medium: 5g/L of glucose, 10g/L of peptone, 5g/L of yeast extract and 10g/L of NaCl.
8. Use of the recombinant coryneform bacterium according to claim 1 for the production of L-lysine.
9. The use according to claim 8, wherein the recombinant corynebacterium is inoculated into a liquid LBG medium for seed culture, and then inoculated into a fermentation medium for fermentation culture in an inoculum size of 2-5% by volume;
the LBG medium: 5g/L of glucose, 10g/L of peptone, 5g/L of yeast extract and 10g/L of NaCl;
the fermentation medium comprises: 100g/L glucose, 20g/L peptone, 30mL/L corn steep liquor, 5g/L urea, (NH)4)2SO425g/L, L-leucine 0.34g/L, KH2PO4 2g/L,MgSO4·7H2O1.5g/L and biotin 0.001 g/L.
10. The use of claim 9, wherein the seed culture conditions are 200-220 rpm at 28-30 ℃ for 18-25 h; the fermentation culture conditions are 200-220 rpm and 28-30 ℃.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110585915.3A CN113278572B (en) | 2021-05-27 | 2021-05-27 | Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof |
LU102870A LU102870B1 (en) | 2021-05-27 | 2021-11-09 | Recombinant corynebacterium strain for modifying 5'-end sequence of 4-hydroxy-tetrahydrodipicolinate synthase (hts) gene and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110585915.3A CN113278572B (en) | 2021-05-27 | 2021-05-27 | Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113278572A true CN113278572A (en) | 2021-08-20 |
CN113278572B CN113278572B (en) | 2022-11-25 |
Family
ID=77282228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110585915.3A Active CN113278572B (en) | 2021-05-27 | 2021-05-27 | Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113278572B (en) |
LU (1) | LU102870B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8637295B1 (en) * | 2009-02-20 | 2014-01-28 | Evonik Degussa Gmbh | Process for the production of L-lysine |
CN109486845A (en) * | 2018-12-18 | 2019-03-19 | 江南大学 | A kind of method of control accurate Corynebacterium glutamicum gene expression |
CN110106206A (en) * | 2019-05-14 | 2019-08-09 | 诸城东晓生物科技有限公司 | A kind of corynebacterium glutamicum construction method improving L-lysine yield and stability |
CN111197021A (en) * | 2020-01-13 | 2020-05-26 | 江南大学 | Recombinant corynebacterium glutamicum with improved L-lysine yield and construction method thereof |
-
2021
- 2021-05-27 CN CN202110585915.3A patent/CN113278572B/en active Active
- 2021-11-09 LU LU102870A patent/LU102870B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8637295B1 (en) * | 2009-02-20 | 2014-01-28 | Evonik Degussa Gmbh | Process for the production of L-lysine |
CN109486845A (en) * | 2018-12-18 | 2019-03-19 | 江南大学 | A kind of method of control accurate Corynebacterium glutamicum gene expression |
CN110106206A (en) * | 2019-05-14 | 2019-08-09 | 诸城东晓生物科技有限公司 | A kind of corynebacterium glutamicum construction method improving L-lysine yield and stability |
CN111197021A (en) * | 2020-01-13 | 2020-05-26 | 江南大学 | Recombinant corynebacterium glutamicum with improved L-lysine yield and construction method thereof |
Also Published As
Publication number | Publication date |
---|---|
LU102870B1 (en) | 2022-05-10 |
CN113278572B (en) | 2022-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6679803B2 (en) | New promoter and its use | |
CN110106206B (en) | Corynebacterium glutamicum construction method for improving yield and stability of L-lysine | |
CN113278571A (en) | Construction method and application of corynebacterium engineering bacteria | |
CN111411092A (en) | Corynebacterium glutamicum with high L-lysine yield and application thereof | |
CN113201524B (en) | Inositol-3-phosphate synthase mutant and application thereof in constructing corynebacterium glutamicum capable of producing glutamine at high yield | |
WO2022017223A1 (en) | Mutant of pyruvate carboxylase gene promoter and use thereof | |
CN113308426B (en) | Recombinant corynebacterium for modifying TK gene 5' terminal sequence and application thereof | |
CN114426983B (en) | Method for producing 5-aminolevulinic acid by knocking out transcription regulatory factor Ncgl0580 in corynebacterium glutamicum | |
CN111154748A (en) | Acetohydroxy acid synthase mutant for improving L-isoleucine synthesis purity | |
CN113278572B (en) | Recombinant corynebacterium for modifying 5' -terminal sequence of HTS gene and application thereof | |
CN114957414B (en) | RosR mutant, recombinant microorganism thereof and application thereof | |
CN112538491B (en) | YH66_08550 gene-based recombinant strain for producing L-isoleucine as well as construction method and application thereof | |
CN112080534B (en) | Engineering bacterium for high yield of L-amino acid and construction method and application thereof | |
TWI789734B (en) | Novel promoter and method of producing glutathione using the same | |
CN113308425A (en) | Method for improving yield of L-lysine of corynebacterium glutamicum recombinant strain | |
CN115490761B (en) | Recombinant microorganism constructed based on lysine efflux protein and method for producing lysine | |
CN111979257A (en) | Recombinant DNA and application thereof | |
RU2802274C1 (en) | New variant of branched-chain amino acid aminotransferase and a method of producing leucine using it | |
CN116262915A (en) | 3-isopropyl malate dehydratase mutant and application thereof | |
CN115029289A (en) | Genetic engineering bacterium for high yield of L-threonine and construction method and application thereof | |
CN117247914A (en) | Acetohydroxyacid synthase mutant and application thereof | |
CN116334112A (en) | Construction method and application of amino acid production strain | |
CN117165545A (en) | Alpha-isopropyl malate synthase mutant, recombinant microorganism and application thereof | |
CN117701519A (en) | Mutant of enzyme for biosynthesis of branched-chain amino acid, construction method and application thereof | |
CN117586977A (en) | Branched chain amino acid aminotransferase mutant, recombinant microorganism and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 250300 No. 3501 University Road, Changqing District, Jinan City, Shandong Province Patentee after: Qilu University of Technology Patentee after: Dongxiao Biotechnology Co.,Ltd. Address before: 250300 No. 3501 University Road, Changqing District, Jinan City, Shandong Province Patentee before: Qilu University of Technology Patentee before: ZHUCHENG DONGXIAO BIOTECHNOLOGY Co.,Ltd. |